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INTRODUCTION 
One of the most striking advances made in the field of 
chemotherapy was the discovery of remarkable curative properties 
of the red azo dye, prontosil. This discovery led to the syn- 
thesis of a host of compounds containing the sulfanilamide group. 
Many workers studied the metabolism and fate of different com- 
pounds of sulfanilamide in Itrious species (30, 65, 77, 126). 
It was found that the main metabolic reaction of sulfanilamide 
in most animal species, including man, was hepatic acetylation. 
It was stated that the spleen participated in acetylation in cats 
(123), and dogs did not acetylate sulfanilamide drugs. Marshall 
(76) and Shaffer and Bieter (108) showed that acetylation takes 
place normally in dogs and fowl. However, deacetylation occurs 
in dogs and fowl before urinary excretion. Krebs, et al. (65) 
and Marshall, et al. (77) demonstrated that the acetylated 
sulfanilamide was less soluble and more toxic than the parent 
drug. Consequently, efforts have been made to obtain a more 
soluble sulfanilamide, of which the acetyl derivative was also 
relatively soluble and less toxic than that of the earlier drugs, 
without loss of therapeutic efficacy in the parent drug. This 
seems to have been achieved in 3:4-dimethyl-5-sulfanilamidoisox- 
azole (grantrisin). However, interest in the metabolism of 
sulfanilamide remained, because some of the toxic effects of 
these compounds were found to be due to metabolites, particularly 
the acetyl derivatives. The governing factors and mechanism of 
acetylation has been investigated. It was shown that the degree 
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of acetylation as less in thiamine, riboflavin, and biotin de- 
ficient animals (79). Folic acid was illustrated as a necessary 
component in acetylation mechanisms (56). It has been depicted 
that acetate or acetyl acid derivatives influence the acetyla- 
tion (79). It was demonstrated (74, 89) that vitamin A takes 
part in acetylation mechanism in biosynthesis of mucopolysac- 
charides, cholesterol and detoxication mechanisms; but how 
vitamin A influences sulfanilamide acetylation is not known. 
There is no indication in the literature that vitamin E 
takes part in acetylation mechanisms, but it is closely inter- 
related to vitamin A in its biological activities. It is said 
(89) to have "a synergistic effect" on vitamin A. It has been 
shown that vitamin E probably plays a greater role on enzymic 
activities of the body (105, 107). 
Nutritional deficiencies are very common among livestock, 
particularly of vitamins A and/or E. The role of these vitamins 
in metabolism and maintaining certain tissues and organs in a 
healthy and functional status has been studied. The toxicity of 
sulfanilamide has been studied, and it was reported (112) that 
it mainly affects the kidney, liver and blood where vitamin A 
and/or i has some influence. 
PURPOSE OF STUDY 
Sulfanilamide drugs are employed extensively in large animal 
practice. Nutritional deficiencies particularly avitaminosis A 
and/or E and related disorders are common among livestock. The 
effects of sulfanilamide in these conditions has not been 
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studied. The experiments herein reported were designed to in- 
vestigate: 
(a) The effect of sulfanilamide treatment in vitamin A and/ 
or E deficient rabbits; 
(b) The toxicity of sulfanilamide in deficient animals and 
making histopathological examination of vital organs for possible 
changes; 
(c) The changes in certain blood and urinary constituents 
such as urinary quantity, urea nitrogen, creatine, creatinine, 
and packed cell volume values; and 
(d) The effect of sulfanilamide on live body veight. 
RaIE";' OF LITZRATURE. 
Metabolism and Excretion of Sulfanilamide 
Sulfonamide drugs are absorbed more or less readily from the 
gastro-intestinal tract. The speed is varied with the compounds 
of different structural formulas. Oral administration of sulfa- 
nilamide is absorbed completely because of its increased solu- 
bility. Metabolism of sulfanilamides continued to be of interest, 
because some of the toxic effects of these compounds were found 
to be due to their metabolites, particularly the N4-acetyl deriv- 
atives which are more toxic and less soluble than the parent drug. 
The main metabolic reaction of sulfanilamide in most animal 
species, including man, was acetylation. Marshall, et al. (77), 
Gilligan (30), and oalliams (126) reported that the acetylation 
occurred to a variable extent which was usually about half of the 
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dose. Dogs did not acetylate sulfanilamide or any of its deriva- 
tives, a point which had been investigated by Marshall (76) and 
Krebs, et al. (65). 
Harris and Michel (40) reported that the liver of rabbits and 
rats was the site of acetylation of the sulfanilamides. Van -Win- 
kle and Cutting (123) reported that the spleen also participated 
in acetylation in cats. Martin and Rennebaum (79) studied the 
degree of acetylation of sulfanilamides with different chemical 
compounds. They noticed a decrease of acetylation in deficiency 
of thiamine and riboflavin. Sollmann (112) quotea that Suo- 
malainen and Kinnunen injected thiamine into rabbits, which in- 
creased the acetylation threefold, and they suggested that the 
acetylation involved the diphosphothiamine redox system. Johnson 
(56) reported that folic acid was necessary in the acetylation 
mechanism. Acetylation of sulfanilamide and its derivatives in 
pigeon liver extracts was markedly noncompetitively inhibited by 
4-aminoanalogues of folic acid and aminopterin which are folic 
acid antagonists. 
Lipmann (69) reported that the homogenized liver pulp acety- 
lated considerable sulfanilamide if aerated, very little if air 
was excluded. Addition of acetate doubled the amount of acety- 
lation, and acetoacetate and pyruvate increased it to a lesser 
degree. Blondheim (9) reported that the plasma appeared to con- 
tain the precursor of the acetate. Fraenkel-Conrad and Green- 
burg (28) recorded an increase in acetylation of administration 
of thiouracil, and a decrease by thyroid administration. Hitch- 
cock and Nelson (51) reported that paraldehyde increased the 
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acetylation of sulfanilamides. 
Recently, the deacetylation mechanism of sulfanilamides has 
been studied in dogs and fowl. Marshall (76) made a comment that 
the dog actually acetylated the sulfa drugs which were then de- 
acetylated before excretion. Shaffer and Bieter (108) described 
the acetylation of sulfanilamide occurring in the liver of the 
chicken, and the compound was deacetylated by an active deacety- 
lase enzyme present in the kidney. Bray, et al. (12) have dis- 
tinguished two types of deacetylating enzymes, namely, acetyl- 
glycinedeacetylase and acetanilide deacetylase, found in liver 
and kidney, but their occurrence depended upon species. Krebs, 
et al. (65) suggested that the acetylation depended upon a com- 
petition between the acetylating and deacetylating enzymes. 
Davis (22) indicated from dialysis experiments that some of 
the sulfanilamide drug was bound by albumin of the plasma but not 
by globulin or lipoids. This increased the solubility, but only 
the unbound drug was bacteriostatic. Stowe and Sisodia (114) 
investigated the pharmacological properties of sulfanilamides in 
aairy cattle. They reported that the drug was bound to plasma 
protein, urine, and milk. The presence of the drug in the milk 
was explained on the basis of pH partition and the passive dif- 
fusion concept. 
Sulfonamides are primarily excreted by the urinary system. 
Small amounts of sulfonamides are excreted in bile, pancreatic 
juice, gastric juice, intestinal juice, and in milk. However, 
solubility is dependent upon pH, and both sulfanilamide and its 
acetyl derivatives are more soluble at alkaline than at acid pH 
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values. As the glomerular filtrate passed through the urinifer- 
ous tubules, the reabsorption of the bicarbonate and other useful 
ions lowered the pH of the filtrate, favoring the precipitation 
of the sulfanilamides (58). Antopol and Robinson (2) have found 
uroliths in rats, rabbits and monkeys after feeding them the 
sulfanilamide for several days. Beyer, et al. (8) reported that 
liberal water consumption, intravenous injection of dextrose, or 
administering bicarbonate interfered with tubular reabsorption 
anu, at the same time, increased the solubility of the conju- 
gated compound of the sulfanilamide. Berliner (7) reported that 
a massive dose of sulfanilamide decreased the urinary acidity, 
presumably through inhibition of carbonic anhydrase which facil- 
the excretion of sodium ions. 
Sulfanilamide Toxicity 
Sulfanilamides differ in kind and degree of toxicity, which 
depends on the compound used and on sensitization of the body. 
Murayama and Laeke (92) administered orally a single dose in 
acacia suspension to rats, which produced no fatality at 3 gm., 
20 per cent at 4 gm., and 50 per cent at 10 gm. per kg. of body 
weight. One gm. per kg. of body weight caused gradual loss of 
weight and produced enlarged spleens. Four-tenths per kg. elic- 
ited no effect through intraperitonial injection into rabbits. 
One and one-half gm, per kg. promoted marked symptoms, such as 
weakness of legs, dyspnea and spasticity. Some rabbits showed 
chromatolysis of the central nervous system, especially in the 
spinal cord, with 2 gm. The surviving rabbits demonstrated 
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alterations in the liver and kidney. Kohn-Richards (61) reported 
that the toxic effects resemble those of picrotoxin and urethane. 
Mendenhall and Shreeve (82) administered various sulfanil- 
amides to dogs and observed no effect on the heart muscle. 
cised frog heart was stimulated utilizing 0.25 per cent and 
slowed or arrested employing 0.5 per cent of sulfanilamide. 
Litchfield (70) reported that the skeletal muscle of frog was 
aepressed by immersion in sulfanilamide solution. 
Kellen and Mann (60) and Henesch, et al. (5) observed that 
the calcification of the eggshell of birds was inhibited by feed- 
ing sulfanilamide. Inhibition of calcification of eggshell 
occurred without other symptoms and has been attributed to in- 
hibition of carbonic anhydrase, which was presumably necessary 
for shell formation. 
Haerews (38) reported that sulfanilamide appeared to have a 
low-incidenced carcinogenic tendency in rats and mice, regardless 
of method of administration. Greisheimer, et al. (34) showed 
different effects on the blood sugar level, liver glycogen forma- 
tion and storage by various sulfanilamides. Mackenzie and Macken- 
zie (72) reported that the basal metabolic rate of rats dropped 
sharply when sulfanilamides were fed. This was accompanied by 
thyroid hyperemia and hyperplasia (thyroid deficiency), including 
changes in the cells of the anterior pituitary. Astwood, et al. 
(3) remarked that the hyperplasia was due to failure of thyroxine 
synthesis. 
Kracke (63) reported that cyanosis occurred in most patients 
with sulfanilamide. Richardson (102) cited that the mechanism 
of cyanosis was due to the formation of sulfhemoglobin, which 
was dependent on the sulfur content of the diet, and that it was 
increased by giving thiosulfate, sulfur, and potassium sulfonate. 
James (54) showed that the oxidation of sulfanilamide by hydrogen 
peroxide also resulted in colored oxidation products which were 
absorbed by the fat of the red corpuscles envelope without af- 
fecting the oxygen carrying capacity. Oxidation products of 
sulfanilamide have been isolated from the urine and have been 
attributed to the development of cyanosis in the absence of 
methemoglobin and sulfhemoglobin. 
Hemolytic anemia, jaundice, and secondary anemias have been 
noticed by many workers (49, 61). Higgines and Machella (49) ad- 
ministered large doses (1 gm.) of sulfanilamide in white rats, 
which elicited a marked decrease of the red blood cells and other 
macrocytic anemia changes. Southworth (113) reported that sulfa- 
nilamide lowereu the carbon dioxiue combining power of the blood 
in man. Mann and Kellen (73) attributed that the cause was the 
specific inhibition of carbonic anhydrase, which have been demon- 
strated in sulfanilamide alone. Kracke and Townsend (62) reported 
a uecrease of blood platelets in sulfanilamide therapy. A de- 
crease of the prothrombin levels by inhibition of the bacterial 
flora of the intestine by sulfanilamides was observed by Daft, 
et al. (19). 
Herbut and Scaricacottoli (45) and Lodge and Woodcock (71) 
noticed diffused necrosis of the liver in sulfanilamide toxicity. 
histological liver injury was studied by Menten and Andersch 
(83). histopathological studies of long duration a ministration 
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of sulfanilamide in rats (3 months to 1 year) were made by Gray 
(32). 
The most important toxic reactions produced by sulfanil- 
amide therapy in domestic animals are chronic in nature. The 
most significant reaction is renal toxicity. Vilter and Blank- 
enhorn (124) reported that sulfanilamide promoted direct renal 
lesions, tubular or interstitial, which were not dependent upon 
renal obstruction. Jones (58) described that the sulfanilamides 
were concentrated about fifty times while passing from the renal 
glomeruli through the uriniferous tubules of the normal kidney. 
The tendency for crystallization to occur was increased by the 
normal reabsorption of tne alkaline sodium ions in the renal 
tubules, which lowered the pH of the urine and solubility of the 
sulfanilamide. The needle-like crystals of precipitated sulfa- 
nilamides punctured and ruptured the mucosal cells of the urinary 
tract. Crystals became sufficiently numerous to form calculi 
which obstructed the collective tubules, the renal pelvis, or 
the ureters. Histopathological studies were investigated by 
Antopol and Robinson (2) and Prien (98). They observed nephro- 
sis with an absence of crystalluria. 
In addition to these toxic reactions, certain other toxic 
symptoms, such as nausea, vomiting, skin eruptions, conjuncti- 
vitis, nervous disturbances, drug fever, suppression of egg 
production and acidosis have been noted after the administration 
of sulfanilamides (112). 
10 
Vitamin A and Its Relation to Vitamin 1, 
The quantities of vitamin A absorbed and stored by mammals 
vary widely between species and individuals of the same species. 
Age is one factor which influences vitamin A, since the liver of 
most newly born animals contains only small amounts of the vitamin. 
The value for the liver reserve vitamin A of a rabbit was 
150 I.U./gm. liver weights (88). It was evident that the high- 
est vitamin A reserve was found in some species of carnivorous 
animals, which presumably derived large amounts of preformed 
vitamin A from liver or other tissues. Herbivorous animals us- 
ually ingest provitamins in amounts which would rapidly saturate 
their livers, if they were efficiently converted to vitamin A. 
In practice, however, the rate of wastage through failure in 
mal-absorption and other causes was very high. Sheep accumu- 
lated the most vitamin A (600 I.U./gm. liver). This difference 
was believed to be related to a greater conversion efficiency of 
carotene to vitamin A in the intestinal mucosa of sheep, as evi- 
denced by the absence of yellow pigments in their blood plasma 
and body fat. 
V,hite body fat, however, does not insure that a species of 
animals would be able to accumulate large stores of vitamin A 
when given a provitamin diet. Bentley and Morgan (6) found that 
most guinea pigs, in spite of their colorless fat, accumulated 
notably low reserves of vitamin A when they were given a diet 
containing green vegetables. They were quite efficient, however, 
in storing preformed vitamin A. They also stated that guinea 
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pigs contained only about 10 I.U./gm. as compared with 150 I.U./ 
gm. in rabbits receiving the same diet. 
In 1929, Moore (85) found that the removal of the usual fat 
components from a basal diet of rats did not noticeably affect 
the biological activity of a liberal dose of carotene, which was 
administered in a drop of archis oil. Wilson, Ahamad, and Ma- 
junder (127) confirmed the above and reported that the inclusion 
or exclusion of fat had little effect on growth, but the reserves 
of vitamin A in the liver tended to be higher in those groups re- 
ceiving fat. Russell, et al. (106) reported that hens absorbed 
less carotene when their diet contained only 0.1 per cent of fat 
than 4.0 per cent. Carotene produced better growth responses 
when the diet contained 5 per cent lard than when the diet con- 
tained no fat. 
Kraybill and Shrewsbury (64) compared the growth promoting 
power of graded doses of carotene in rats, administered either 
in cottonseed oil or butterfat, which haa been decolorized by 
Lloyd's reagent. The provitamin was 2-3 times more effective 
eruploying the cottonseed oil as diluent. Sherman (110) pointed 
out that his findings on different natural oils could usually be 
explained oy a physiological antagonism between unsaturated fatty 
acids and vitamin influencing the metabolism of carotene. 
Moore, et al. (90) observed that a deficiency of vitamin E 
in rats elicited less storage of vitamin A. It was reported that 
vitamin r, promoted less effect on the storage of vitamin A derived 
from carotene than on the storage of preformed vitamin A (86). 
Hickman and his colleagues (47, 48) stated that tocopherol 
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acted by reason of its antioxidant power on stabilizing carotene 
in the intestinal tract. Thus, free tocopherols were more ef- 
fective than esterified tocopherols, which agreed with the find- 
ings that the tocopherols only protected fats from oxidation in 
vitro when they were added in free form. Tests utilizing human 
volunteers suggested that tocopherol increased the excretion of 
carotene in the feces due to diminished absorption (48). 
Quackenbush, et al. (99) examined the effect of alpha to- 
copherol and other antioxidants, in relation to increasing the 
stability and growth promoting power of carotene. Alpha tocoph- 
erol and hydroquinone were equally effective as antioxidants 
in vitro. 
Guggenhein (36) studied the efficiency of absorption of 
carotene from various vegetables as measured by storage of vita- 
min A in the liver of rats. He concluded that the efficiency of 
storage depended upon the tocopherol content of the vegetable. 
Tomarelli and Gyorgy (119) observed that rice bran extracts 
contained a factor which could further support the action of 
tocopherol by increasing the growth response with small doses of 
carotene. Rao (100) found that the difference between the growth 
responses produced by solutions of carotene in arachis oil, co- 
conut oil and olive oil were greatly reduced when the vitamin E 
contents of the oil were equalized by adding tocopherol to the 
coconut and olive oils. 
Hickman, et al. (48) noted that small doses of tocopherol 
increased the utilization of carotene, as measured by growth 
responses, and larger doses promoted the reverse effect. Johnson 
13 
and Barman (57) found that small doses of tocopherol had little 
effect on the utilization of carotene, as measured by storage of 
vitamin A; on the other hand, larger doses considerably decreased 
the storage of vitamin A. Swick and Baumann (116) indicated that 
high doses of alpha-tocopherol acetate and gamma tocopherol had 
the same effect as alpha-tocopherol. 
According to High, et al. (50) other antioxidants might 
vary in their effect on carotene metabolism, according to dos- 
age. Thus, in rats, daily dosage of 0.5 mg. acetylhydroquinone 
promoted the storage of vitamin A accumulation following admin- 
istration of 50 I.U. doses of carotene, but 10 mg. produced 
decreased storage. Moore (87) cited that Bernhard and associ- 
ates claimed the bile pigments, bilrubin and biliverdin acted 
as antioxidants for vitamin A. 
Moore (87) noticed that the vitamin A reserves of rats which 
had been maintained for long periods on deficient diets of vita- 
min were invariably lower than in rats treated with vitamin E. 
Advanced deficiency of vitamin E accelerated the loss of vitamin 
A which had been stored in the liver, when fed on deficient diet. 
This finding explained the failure of the liver preserving power 
rather than the intestinal absorbing power. 
The protection of vitamin b on preformed vitamin A during 
its absorption from the intestinal tract was studied by Hickman 
and his colleagues (47). 
The effect of mixed tocopherols in aiding growth and in- 
creasing storage of vitamin A in rats was confirmed by Lemley, 
et al. (67). They emphasized that the action of tocopherol 
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could only be demonstrated under suitable experimental condi- 
tions. Thus, growth was promoted at low dosages of vitamin A, 
but depressed at higher levels. Liver storage of vitamin A was 
not influenced when vitamin B was given witn or without tocoph- 
erol for 3 days, but considerable differences were found when 
treatment was continued for several months. Davis and :400r (21) 
stated that vitamin A reserves were decreased with prolonged de- 
ficiency of vitamin E, and vitamin A deficiency occurred as a 
secondary effect to vitamin deficiency. 
Goerner (31) reported that carcinogenic agents- -like 1,2; 
5,6-dibenzanthracene, 2-amino-5-azotoluene and methyl- chrolan- 
threne-- decrease the liver vitamin A. 
Work by Bacharach (4), in which rats were maintained on an 
avitaminosis E regimen for a comparatively short period of 14 
weeks, treating with vitamin E elicited an improvement of 50 
per cent in the storage of vitamin A. Burgess, et al. (13) re- 
ported that the addition of penicillin to the diet of chicks 
promoted blood and liver vitamin A content, whereas aureomycin 
had little effect on vitamin A. Atropine was found by Inge- 
finger, et al. (52) to reduce the absorption of vitamin A, as 
evidenced by partial or complete suppression of the increased 
blood vitamin A following massive vitamin dosage. They commented 
that the drug produced a reduction of the motor activity of the 
small intestines. Guggenhein (37) reported that when rats were 
given prolonged treatment utilizing antimalarial drug (atabrine) 
liver storage capacity for vitamin A was adversely affected. 
however, even toxic levels of atabrine did not apparently 
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accelerate the appearance of deficiency symptoms in rats which 
were deprived of vitamin A. 
More extensive studies confirmed the presence of vitamin A 
in the liver, lungs, kidneys, and suprarenal glands (96, 97). 
The authors stated that vitamin A was distributed in several 
liver areas of normally nourished animals. Goerner (31) reported 
the presence of vitamin A in the liver cell mitochondria of rab- 
bits. The work of Ganguly, et al. (29) suggested that in the 
liver cell, free vitamin A was associated with protein and 
esterified vitamin A with fat. 
Young and Wald (134) observed the mobilization of vitamin A 
by stimulating the splanchnic nerve but not the cervical sym- 
pathetic nerves. Young and his colleague (134) noted that in- 
jections of adrenaline were effective in raising blood plasma 
vitamin A of rabbits. Chapman, et al. (15) observed that es- 
tradiol strengthened the power of the liver to absorb vitamin A, 
and that testosterone would depress the action. Crowley and 
Allen (18) indicated that ethyl alcohol increased the blood 
vitamin A of calves and goats. 
Lewis, et al. (68) and Sherman and Trupp (109) studied the 
growth rate of rats with different allowances of vitamin A. 
Davis and Moor (20) demonstrated that rapid loss of vitamin A 
occurred during the first week of avitaminosis A with much 
slower losses during later weeks. 
Vitamin A and Metabolism 
The function of vitamin A in metabolism is not known. In 
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early work, ;olf and Johnson (130) cited that Von Euler and 
Schmidt reported the principle role of vitamin A was the stimu- 
lation of the building of cells through possible role in the 
nucleic acid metabolism. They also suggested a possible con- 
nection of vitamin A with oxidation reactions, which increased 
oxygen consumption in liver tissue with increased amounts of 
vitamin A. Ray and Sadhu (101) attributed their findings to a 
wide-spread depression in metabolism induced by hypervitamin- 
osis A. Rosenberg (103) stated that vitamin A seems to exert 
some specific function concerning fat and carbohydrate metabo- 
lism. This is, fat, cholesterol, and glycogen content of the 
organism decreased during vitamin A deficiency, whereas excess 
doses promoted an increase. Ray and Sadhu (101) noted that 
hypervitaminosis A caused a decrease in liver glycogen and in- 
crease in liver fat. 
With radioactive studies (130) it was found that vitamin A 
deficiency was without effect on the tricarboxylic acid cycle in 
the rate of acetate oxidation to carbon dioxide. It was also 
found (130) that there was no effect of vitamin A deficiency on 
the connecting link between the tricarboxylic acid cycle and 
glycolysis (representative of pyruvate and oxalacetate, respec- 
tively). biosynthesis of glycogen was markedly depressed in the 
severely deficient animals. In in vitro studies (130) it was 
found that glucose-6-phosphate dehydrogenase, hexokinase, phos- 
phorylase, and transdehydrogenase in the liver were unaffected 
by vitamin A deficiency. 
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Vitamin A and Detoxication 
Manville (74) examined the pathological effects of inter- 
ference in mucous formation by dosing rabbits with methanol. 
Methanol was detoxified by combining with glucuronic acid. Fre- 
quent administration of methanol produced lesions resembling 
avitaminosis A. 
Moore (89) cited that Meunier and co-workers studied the de- 
toxication of sodium benzoate with different dosages of vitamin A 
and observed that rats died from vitamin A deficiency. Moore (89) 
quoted that Ferrando investigateu the effect of vitamin A defi- 
ciency on the urinary components of rats given sodium benzoate. 
Total nitrogen, urea, creatinine, and creatine was increased, 
while glucuronic acid decreased in the deficient animals when 
compared to the control -,roup. He regarded the conjugation of 
benzoate with glucuronic acid as a "sortie de secours" additional 
to its detoxication as hippuric acid by combining with glycine; 
and apparently this mechanism was severely affected by the ab- 
sence of vitamin A. 
Moore (89) mentioned that Haley and Samuelsen and ;..eunier 
and his colleagues studied the deterioration of monobromobenzene 
employing various daily dos,,s of vitamin A, which was very 
effective. 
Moore (89) cited that Lasch noticed the cholesterol (sterol) 
level was increased after administering massive doses of vitamin A. 
Green, et al. (33) found no abnormality in blood plasma and liver 
cholesterol levels of avitaminosis A rats. 
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Vitamin A and 'ucopolysaccharides 
The first manifestation of vitamin A deficiency is a dis- 
ruption and atrophy of all the epithelial tissues of the respir- 
atory, intestinal and urinary tracts, and genital system that 
function in mucus secretion. Ultimi=tely the mucus-secreting 
tissue is replaced by keratinization. Chondroitin sulphate of 
cartilage is affected by the deficiency of vitamin A (84). 
Meyer (84) isolated three different chondroitin sulphates. 
Chondroitin sulfate A is a polymer of D-glucuronic acid and 
sulfated N-acetylgalactosamine with an N-acetylchondrosine sul- 
fate 1, chondroitin sulfate 13, and chondroitin sulfate C. Meyer 
(84) quoted that earner extracted three main types from pig colon 
aucosa, which he called (1) fucomucin contained N-acetyiglucosa- 
mine, N-acetylgalactosamine and D-galactose; (2) sialomucin 
contained N-acetylgalactosamine; and (3) the identity was in 
question. 
The pathway of biosynthesis of acid mucopolysaccharides was 
recently cleared by Markovitz, et al. (75). They showed that 
the acetylation by coenzyme A produced N-acetylglucosamine 6- 
phosphate from glucosamine-6-phosphate. "e;olf and Varandani (131) 
investigated the localization of the function of vitamin A in a 
specific step in mucopolysaccharide biosynthesis. They also ob- 
served in vitro that vitamin A demonstrated an influence on 
mucopolysaccharide--bound hexosamine ( acetylation of hexosamine). 
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Vitamin A and the Urinary Tract 
In addition to the pathology of the respiratory tract, in- 
testinal tract, and salivary glands, the urinary tract should be 
given important consideration. Wolbach and Howe (129) found 
that in their deficient rats the kidney's pelvis was replaced 
by keratinized epithelium. The ureters, pelvis, and bladder 
showed a down-growth of epithelium and formations of dermoid- 
like cysts in the bladder. Tyson and Smith (120) commented that 
the first stage appeared to be a piling up of the epithelium with 
infiltration of the subepithelial tissues with neutrophiles, and 
the second stage produced keratinized epithelium. Harris, et al. 
(41) noted hyperplasia in the kidney pelvis. 
Van Leersum (122) followed with histological and radial 
studies after confirmation that calculi could readily be pro- 
duced by giving a vital in A deficient diet. Calculi were present 
in 13U of 297 males and 67 of 348 females. He found that the 
urine was usually acid. There was no infection, but hematuria 
was frequent. The deposits appeared to originate in the calci- 
fication of keratinized epithelium in the kidney tubules. Casts 
were dislodged and served as foci for calcification in the kid- 
ney pelvis, ureters, and bladder. Most of the calculi consisted 
of calcium, ammonium or magnesium phosphates, but concrements of 
calcium oxalate also were common. The question of specificity 
of the relationship between avitaminosis A and urolithiasis has 
given rise to controversy. Moore (88) cited that McCarrison and 
Raganathan found stones when excesses of calcium were given in 
20 
conjunction with a low protein diet but adequate in vitamin A. 
McCollum and Simonds (80) confirmed the effect on stone forma- 
tion of a high calcium to protein ratio. It seemed that uro- 
lithiasis may arise from different defects. 
Vitamin A and Liver 
Particular interest in avitaminosis A effects on the liver 
may arise from its importance as the main storage depot of vit- 
amin A. Early investigations gave no indication that the liver 
was seriously affected by deprivation of the vitamin. olfe and 
Salter (132) reported a reduction in liver size, which they at- 
tributed to the loss of glycogen and fat. Gross (35) noted liver 
congestion. Thatcher anc Sure (118) observed that the area 
around the portal space had become fibrous. Moore (88) quoted 
that De Kuyter described abnormalities in the reticulo-endo- 
thelial system (Kupffer cells of the liver). Bile duct injury 
by lack of vitamin A has been reported with formation of stones 
in the bile ducts or gall bladder. Hamre (39) found dilated 
bile ducts, accompanied by some degree of jaundice in avitamin- 
osis A animals. Metaplasia of the epithelial lining was observed. 
The ducts became obstructed, and calculi of varying sizes and 
composition were formed but entailed a nucleus of detached epi- 
thelial cells. The obstruction of the bile ducts resulted in a 
mild hypertrophy of the portal tract tissues and moderate degen- 
erative changes of the peripheral parenchymal tissues of the 
hepatic lobules. 
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Vitamin A and Hematological Abnormalities 
Information on the effect of vitamin A deficiency on hema- 
tological abnormalities is not known. 
Sure, et al. (115) found that rats suffering in early stages 
of vitamin A deficiency elicited a slight anemic condition, which 
was characterized by a reduction in either hemoglobin or erythro- 
cytes. After xerophthalmia developed, the values for hemoglobin 
and erythrocytes were raised (probably as the result of anhydre- 
mia). Observations have been reported on avitaminosis A in 
relation to white blood cells. Crimm and Short (17) observed 
that the injections of foreign protein in vitamin A deficient 
animals promoted a high elevation of the leucocyte count (which 
suggested that the reticuloendothelial system was working in- 
efficiently). 
Vitamin E 
Various metabolic relationships of vitamin E have been 
noted to be influenced with other factors which ranged from the 
nutritional to the biochemical. From the nutritional point of 
view, one of the most important of these was the intimate re- 
lationship with vitamin A. The vitamin A-E relationship is 
apparently very complicated, as the factors of this relationship 
have been review previously. 
Several experiments have been conducted to investigate the 
role of tocopherol in metabolism. It was assumed (107) that 
vitamin E was not merely an agent which prevented peroxidation, 
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but rather that it fulfilled a truly catalytic function in enzyme 
systems which was essential for life. Dietary necrotic liver de- 
generation was noted in vitamin E deficiency (107). Cowin and 
Schwarz (16) reported that all areas of substrate utilization in 
the citric acid cycle appeared normal except oxalacetate. The 
impairment of oxalacetate metabolism became evident when malate 
or succinate was employed as substrate in the presence of diphos- 
pho-pyridine nucleotide. Accumulation of oxalacetate elicited a 
negative feedback inhibition of the oxidation of succinate and 
malate (107). Adenosine triphosphate, acetyl co-enzyme A, man- 
ganese, and magnesium ions were found to prevent the condition. 
It was suggested (107) that the liver damage caused by 
bromobenzene was due to removal of methionine and cystine. Vit- 
amin E could prevent the liver damage but not the intoxication. 
A-variety of papers, including those of a conflicting 
nature, are present in the literature relating to the effects 
of a vitamin E deficiency of different enzyme systems. Jacobi 
and co-workers (53) observed no changes in malic dehydrogenase, 
cytochrome oxidase, succinic dehydrogenase, lactic dehydrogenase, 
fumarese and adenosinetriphosphatase activities of muscle from 
rabbits suffering from muscular dystrophy. Rosenkrantz (105) 
found a decrease in the activity of ketoglutaric dehydrogenase 
and isocitric dehydrogenase in the terminal stage of dystrophic 
muscle of rabbits. Addition of vitamin E inhibited liver 
esterase (121) and liver acid phosphates° (53). 
Hemolysis of erythrocytes (107), decrease oxygen consumption 
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(104), and muscular dystrophy (10) have been reported in avita- 
minosis E. 
Oppenheimer and associates (93) showed that in E deficient 
rabbits there was a decrease in alpha-lipoprotein and serum al- 
bumin, but an increase in beta-lipoprotein and beta-globulin. 
Protein-bound carbohydrates were decreased. Moore (91) reported 
that vitamin E prevented renal histolysis. Tamura and co-workers 
(117) indicated that vitamin E protected the liver of rats from 
carbon tetrachloride intoxication. 
Urea Nitrogen 
It has been illustrated (14) that urea is formed in the 
liver from ammonia derived from amino acid digestion during the 
process of deamination. The end product of the catabolism of 
amino acids was mainly excreted in the urine. Urea excretion 
was considered to be a good index of the functional status of 
the liver and kidney in the animal. About 40 per cent of the 
urea which left the blood in the glomerular filtrate was pas- 
sively reabsorbed by diffusion, in the tubules under normal con- 
ditions. Increased blood urea nitrogen was noted in glomerular 
nephritis, inflammation of the kidney, pyelonephritis, sulfa- 
nilamide therapy, urinary tract obstruction, hepatic or biliary 
tract disease, and excessive protein catabolism, while decreased 
blood urea was noted in acute hepatic insufficiency (14). 
Urinary urea was directly proportional to increased blood 
urea (14). McGaughey (81) reported that vitamin E deficient 
mice excreted higher amounts of urea in urine. He stated that 
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the administration of adrenocortical hormones and thyroxine in- 
creased urea excretion. Urinary urea was lowered in renal 
impairment, hepatic insufficiency, and in severe acidosis due 
to decreased formation of urea. Woelfell et al. (128) reported 
that vitamin A deficient calves excreted less urea nitrogen with 
increased volume of urine. Herrin and Nicholes (46) noticed de- 
creased inulin and urea clearances in young vitamin A deficient 
dogs, which are turned to normal following administration of 
vitamin A. 
Creatine and Creatinine 
Creatine is derived from glycine, arginine and methionine, 
ana is important in the phenomenon of muscle contraction as 
phosphocreatine. Creatiniae, the anhydride of creatine and us- 
ually of endogenous origin, is excreted largely by the kidneys. 
It was noted (14) that creatine was not excreted in the urine 
but was absorbed completely by the renal tubules. Its deter- 
minations provided a good index of the functional state of the 
muscle. 
Elevated blood creatinine occurred in any condition in which 
urea WJS increased. Higher blood creatinine was noticed in ne- 
phritis or renal functional impairment, in urinary obstruction 
and in cardiac decompensation (11+). 
Allen (1) and Borgman (10) recorded augmented creatine 
levels in urine of vitamin E deficient rabbits but not creati- 
nine. It was also found in the urine during starvation, febrile 
and wasting diseases, and in certain myopathies. The elimination 
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of increased creatinine was noted in tissue catabolism and 
muscular atrophy. 
Vibelfel, et al. (128) reported a slight lowering of creati- 
nine output in avitaminosis A calves. Pizzolato and Beard (95) 
showed that the injections of vitamin A, thiamine, pyridoxine, 
riboflavin, nicotinic acid, biotin, 2-methylnaphthoquinine, and 
calcium pentothenate did not influence the excretion of creatine 
and creatinine. Injection of cocarboxylase and cebione produced 
a retention in creatinine. Deatherage (23) observed elevated 
excretion of creatine in high fat and protein diets and de- 
pressed excretion in high carbohydrate diets. 
MATERIALS AND METHODS 
Preparation of Assay Animals 
Sixteen New Zealand white rabbits of 4 to 6 weeks of age 
were utilized in the investigations and were divided at random 
into 8 groups, each group consisting of 2 animals. The groups 
were designed as delineated in Table 1. These groups were main- 
tained on basal diet for a period of 15 days to acclimate them to 
the regimen. Each group of 2 animals was kept in a metabolic 
cage for the collection of urine. After 15 days, the rabbits 
were maintained on their respective experimental diets. Writer 
and feed were provided ad libitum. Groups II, IV, VI, and VIII 
were administered sulfanilamide orally in a pill form at the 
dosage of 250 mg./kg./day for 60 days. 
Table 1. Experimental design with number of rabbits on diets. 
Diet : Group number : Number of rabbits 
Balanced basal diet 
Balanced basal diet plus 
oral administration of 
sulfanilamide 
Vitamin A deficient diet 
Vitamin A deficient diet 
plus sulfanilamide orally 
Vitamin E deficient diet 
Vitamin E deficient diet 
plus sulfanilamide orally 
Vitamin A and E deficient 
diet 
Vitamin A and E deficient 
diet plus sulfanilamide 
orally 
I 2 
IT 1* 
ZIT 2 
IV 2 
2 
2 
2 
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* One rabbit died during pre-experimental period. 
Basal Diet 
A modification of a semi -purified vitamin A and L deficient 
diet used by Wooley (133) and Borgman (10) was used. The diet 
was freshly prepared every 8 days and kept under refrigeration. 
The deficient diets were prepared from the same basal diet, omit- 
ting vitamin A and/or vitamin E. The ingredients were as follows: 
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Vitamin-free casein 
Alphacel (Non-nutritive bulk) 
Molecularily distilled lard 
Corn starch 
Sucrose 
Dextrose 
Salt mixture 1 
Potassium acetate 
Magnesium oxide 
Linoleic acid 
Choline chloride 
Inositol 
Ascorbic acid 
30.00% 
15.00% 
20.00% 
6.70% 
9.25% 
8.00% 
6.00% 
2.50% 
0.50% 
0.60% 
0.30% 
0.40% 
0.50% 
P-amino benzoic acid 
Vitamin mixture: 
La./100gm. of diet 
Alpha tocopherol acetate 10.0 
Vitamin A acetate 0.6 
Vitamin D3 0.004 
2 Methyl 1,4 napthoquinone 0.2 
Thiamine hydrochloride 1.6 
Pyridoxine hydrochloride 1.6 
Riboflavin 1.6 
Nicotinic acid 20.0 
Folic acid 0.6 
Biotin 0.6 
Vitamin B12 0.004 
1Salt mixture employed was h. M. 1i. Salt Nixture. 
Experimental Procedures 
After the rabbits were placed on their respective diets, 
they were weighed every third day during the 60-day experimental 
period. Twenty-four hour urine samples were obtained every 
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third day by manually expressing the bladder. Blood samples 
were obtained from the ear vein of each rabbit the day prior to 
the initiation of feeding the respective experimental diets, and 
on the 30th day. Samples of blood were obtained from the heart 
on the last day of the experimental period or on the 60th day 
when rabbits were sacrificed for histological studies. 
Packed cell volume determinations were made by use of the 
Adams' Micro-hematocrit Technique 1 at 0, 30, and 60 days. The pH 
of the urine samples were estimated with pHydrion (B) paper. 
Biochemical Techniques 
Determination of Sulfanilamides in Urine. Determinations 
of urinary sulfanilamides were made by means of a spectrophoto- 
metric technique (78, 11). Each urine sample aws analyzed as 
follows: One ml. of urine was diluted with distilled water in 
a 50 ml. volumetric flask, mixed, and 2 ml. of the diluted urine 
were placed in another flask containing 30 ml. of water. Eight 
ml. of 15 per cent trichloracetic acid were then added into the 
flask, the solution mixed and filtered. 
Free Sulfanilamides. Ten ml. of the trichloracetic acid 
filtrate were transferred into a test tube containing 1 ml. of 
0.1 per cent sodium nitrate and mixed. After 3 minutes, 1 ml. 
of 0.5 per cent ammonium sulphate was added to the contents and 
the tube left standing for 2 minutes. One ml. of 0.1 per cent 
1 
Adams' nicro-hematocrit Centrifuge, Clay-Adams, Inc., 
New York. 
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N-(1-naphthyl) ethylenediamine dihydrochloride was then added 
into the tube for color development. The volume was diluted to 
20 ml. with distilled water. 
Total Sulfanilamide. Ten ml. of trichloracetic acid fil- 
trate were put in a test tube, 0.5 ml. of 4N hydrochloric acid 
was added and the contents mixed thoroughly. The test tube was 
then placed in boiling water for 1 hour, cooled, and made up to 
10 ml. with distilled water. Sodium nitrate, ammonium sulpha- 
mate, and ethylenediamine dihydrochloride were then added as 
mentioned under Free Sulfanilamides, and diluted to 20 ml. 
The Coleman Model 14 Spectrophotometer) was set at 100 per 
cent transmission employing a standard of 8 ml. distilled water 
and 2 ml. of 3 per cent trichloracetic acid utilizing 545 mu 
wavelength. The determinations were calculated by employing a 
graph prepared from utilizing the same technique with known 
quantities of sulfanilamide. 
The average value of the 2 rabbits for each group was taken, 
and the total sulfanilamide excreted in 24 hours was calculated 
with the amount of urine excreted in 24 hours. (The quantity of 
the level given was already known.) 
Total amount of drug excreted in 24 hrs. x 100 = 
Amount of drug administered 
Per cent of total drug excreted in 24 hours. 
The free drug excreted was calculated as mentioned above. 
Per cent of acetylated sulfanilamide was obtained by subtracting 
1 Coleman Instruments, Inc., Maywood, Illinois. 
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the free form from the total drug excreted. 
Determination of Urea Nitrogen in Urine. Urea nitrogen in 
urine was determined employing a modification of two methods 
(27, 135) which was as follows: 
One ml, of urine was diluted to 2 ml. with distilled water. 
One ml. of alcoholic urease solution and 1 drop of sodium phos- 
phate buffer were added to 1 ml. of diluted urine in a test tube. 
(The alcoholic urease solution was prepared by placing 3 gm. of 
pernutite in a flask, washed once with 2 per cent acetic acid 
and twice with distilled water, with 5 gm. of fine jack-bean 
meal and 100 ml. of 30 per cent alcohol. This was shaken gently 
and continuously for 15 minutes and filtered.) This mixture was 
digested in warm water at 42 degrees C. for 10 minutes. The 
contents of the flask were then treesferred to a 100 ml. volu- 
metric flask and diluted to a volume of about 80 ml. A known 
standard was prepared in a second flask containing 0.5 mg. of 
nitrogen and 1 ml. of urease solution, and water was added to a 
volume of 80 ml. One 'al. of 6um ghathi solution was added to 
each flask. Ten ml. of Nessler's reagent r(.1 added to the 
swirled flask contents and diluted immediately to 100 ml., mixed, 
and allowed to stand for 5 minutes. 
The Coleman Model 14 Spectrophotometer wa s adjusted to 100 
per cent transmission employing distilled water blank prepared 
similarly to the standard, except that the standard nitrogen so- 
lution was omitted and the per cent transmission readings were 
recorded at 480 mu wavelength for each sample. 
The average reading of each group was determined and 
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calculated with the amount of urine excreted per kg. body weight 
per day. (As ammonia was insignificantly present in urine, the 
amount of ammonia nitrogen present was not deducted from urea.) 
Creatine and Creatinine Determination in Urine. Urinary 
creatine and creatinine were determined by Folin's method (24). 
One ml. of urine was placed in a 100 ml. volumetric flask, and 
20 ml. of 1 per cent picric acid solution were added and followed 
by 1.5 ml. of 10 per cent sodium hydroxide solution. The con- 
tents were mixed gently and allowed to stand 15 minutes. The 
solution was diluted to 100 ml. with distilled water and mixed 
by inversion. Total creatinine determination was measured by 
placing 1 ml. of urine in a 500 ml. volumetric flask, 20 ml. of 
1 per cent picric acid solution, a few small pebbles, and the 
flask was weighed to the nearest gm. Then, 150 ml. of water 
were added to the contents of the flask and the contents boiled 
for 1 hour. After that, water was added to the flask to the 
original weight of the flask contents and cooled to room temper- 
ature. One and one-half ml. of 10 per cent sodium hydroxide 
were added and allowed to stand for 15 minutes. The contents 
were diluted to 100 ml. with distilled water and mixed by in- 
version. A blank with water and a standard with known amount 
of creatinine were prepared as mentioned above. 
The Coleman Model 14 Spectrophotometer was set at 100 per 
cent transmission with the blank at 520 mu wavelength, and then 
the standard and other sample values were recorded. 
The average readings of each group were determined and cal- 
culated for the amount of urine excreted per kg. body weight per 
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day. The creatirie levels were recorded by subtracting the 
urinary creatinine level from the total level of urinary creati- 
nine. 
Determination of Sulfanilamide in the Blood. Sulfanilamide 
in the blood was determined by the Bratton and :larshall method 
(11). One ml. of oxalated blood was added to 31 ml. of water in 
a 125 ml. Lrlenmeyer flask, mixed, and 8 ml. of 15 per cent tri- 
chloracetic acid solution were added, mixed thoroughly, and 
filtered. The remaining procedure for total and free sulfanil- 
amide was followed as described previously in the determination 
of sulfanilamide in urine. The total sulfanilamide and free 
sulfanilamide present in the blood was calculated per 100 ml. of 
blood. Acetylated form of sulfanilamide was calculated by sub- 
tracting the free form of drug from the total sulfa drug. 
Determination of Blood Urea Nitrogen. This was described 
by Folin and Svedburg (25), Karr (59), and Sobel, Mayer, and 
Gottfield (111). One ml. of oxalated blood was placed in a test 
tube, and 7 ml. of diluted phosphate buffer solution were added. 
A piece of urease paper was then placed in the test tube and the 
contents were mixed thoroughly. The contents were incubated at 
37 degrees C. for 30 minutes, shaking the tube at five-minute 
intervals. After the tube was removed from the incubator, 1 ml. 
of 10 per cent sodium tungstate solution and 1 ml. of 0.9 N 
sulfuric acid were added and allowed to stand for 10 minutes. 
The tubes were centrifuged at 2000 r.p.m. for 10 minutes, 2 ml. 
of the supernatant fluid were pipetted into labeled test tubes, 
8 ml. of water, one drop of gum ghatti solution and 4 ml. of 
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Nesslerts solution were added anti mixed by inversion. The pro- 
cedure was followed by taking 1 ml. of water for blank and 1 ml. 
of standard urea solution for standard. 
The Coleman Moael 14 Spectrophotometer was set at 100 per 
cent transmission with the distilled water blank at 480 mu wave- 
length stanaard, and the samples were read between 14 to 16 
minutes. The concentration of the unknowns was calculated in 
milligrams of urea nitrogen per 100 ml. of blood. 
Determination, of Blood Creatinine and Creatine. Protein- 
free blood filtrate was prepared as described by Folin and ofti 
(26). Two ml. of oxalated blood were placed in a volumetric 
flask and 16 ml. of N/12 sulfuric acid were added and mixed. 
Two ml. of 10 per cent sodium tungstate solution were added 
drop by drop with constant shaking of the flask. The stoppered 
flask and contents were shaken vigorously ana filtered after 15 
minutes. Ten ml. of the protein-free blood filtrate were placed 
in a test tube, 5 ml. of freshly prepared alkaline picrate solu- 
tion were added and the tube allowed to stand for 15 minutes 
(94). A blank with distilled water and a standard with a known 
quantity were also prepared. 
The Coleman Lodel 14 Spectrophotometer was set at 100 per 
cent transmission with a blank at 520 mu wavelength. The con- 
centration of the unknowns was calculated in milligrams of 
creatinine per 100 ml. of blood. 
The total creatinine was determined as follows: 15 ml. of 
protein-free blood filtrate were placed in a test tube, and 1 
ml. of normal hydrochloric acid was added, boiled for about 15 
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minutes at 150 degrees C. and cooled. Then 5 ml. of alkaline 
picric acid solution were added and diluted to 25 ml. with dis- 
tilled water. The samples were calculated as mentioned under 
Blood Creatinine Jetermination. The creatine readings were de- 
termined by subtracting the blood creatinine reading from the 
total blood creatinine readings and are expressed in milligrams 
per 100 ml. of blood. 
Preparation of Histological Sections. After 60 days treat- 
ment with sulfanilamide, the rabbits were sacrificed, autopsied, 
and liver, kidney, urinary bladder, and ureter specimens were 
collected and fixed immediately in 10 per cent buffered forma- 
lin. Histological sections were prepared employing hematoxylin 
and eosin stain and were examined. 
RESULTS 
In the pre-experimental period, one rabbit from each group 
No. II and No. VIII died. The remaining rabbit in group VIII 
died on the 27th day of the experimental period. To compare 
the histological sections of the said rabbit, a rabbit from 
group No. VII was sacrificed at the same time. Results of the 
experiment are delineated in Tables 2-9 and Figures 1 to 8, in- 
clusive. Table 10 shows the averaged values of the various 
constituents of the blood and urine during the 60-day experi- 
mental period for the different groups of rabbits. In order to 
discuss whether the blood and urine constituents of the treated 
groups were increased or decreased over the basal groups, the 
data were converted to percentages, and these data are presented 
in Table 11. 
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Body Weights 
The body weights, as recorded in Table 2 and shown in 
Fig. 1, indicate a great difference in body weights, and the 
rate of growth varied from group to group. Group I, normal 
basal diet rabbits, gained weight uniformly with an average of 
27 gm. per day--that is, about 182 per cent over their initial 
weight--during the 60-day experimental period. The rabbits 
administered sulfanilamide, group II, gained an average of 20.8 
gm. per day in the 60-day period, which was a decrease of 55 
per cent as compared to group I. 
Vitamin A deficient rabbits, group III, gained an average 
of 17.4 gm. per day during the period, which was a decrease of 
69 per cent in relation to control group I. Group IV, vitamin 
A-deficient and sulfanilamide administered rabbits, gained an 
average of 14.8 gm. per day during the treatment, which was a 
decrease of 73 per cent over the control group and 50 per cent 
over group II receiving sulfanilamide. 
The vitamin E. deficient rabbits, group V, did not grow as 
well as the vitamin A deficient rabbits. They gained 13.3 gm. 
per day, which was a decrease of 103 per cent over group I and 
34 per cent over group III. Sulfanilamide administered rabbits, 
group VI, gained 10.1 gm. per day, a decrease of llb per cent 
over group I and 61 per cent over group II, with a difference 
between groups IV and VI of 43 per cent. 
In vitamin A and E deficient animals, group VII, the growth 
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iable 2. Body eights in grs of the experimental rabbits. 
:Days: 0 3 6 9 12 15 18 11 24 27 30 33 36 39 42 45 48 51 54 57 60 
Group I 
Basal diet 
Rabbit 1 910 1210 1306 1374 1528 1590 1678 1730 1820 1938 1990 2060 2104 2166 2210 2300 2350 2400 2484 2562 2604 
Rabbit 2 880 1064 1230 1308 1444 1480 1572 1684 1794 1868 1902 1950 2060 2082 2130 2204. 2230 2280 2300 2410 2428 
Group II1 
'basal diet + 
Julfanilawide 
Rabbit 1 993 1101 1260 1245 1320 1393 1400 1438 1507 1600 1649 1716 1776 1853 1894 1945 2005 2098 2106 2172 2242 
Group III 
Vit. h deficient diet 
Rabbit 1 972 1160 1300 1374 1440 1508 1568 1576 1590 1630 1660 1752 1760 1780 1820 1844 1864 1904 2000 2012 2050 
Rabbit 2 904 1116 1224 1238 1320 1370 1418 1488 1540 1532 1608 1640 1644 1646 1714 1740 1776 1874 1896 1908 1922 
Group IV 
Vit. A deficient diet + 
Sulfanilamide 
Rabbit 1 882 1260 1268 1370 1420 1324 1384 1404 1390 1470 1450 1537 1558 1650 1600 1624 1700 1620 1680 1702 1772 
Rabbit 780 960 1012 1170 1172 1120 1216 1268 1382 1458 1550 1575 1570 1670 1632 1620 1600 1580 1640 1680 1672 
Group V 
Vit. B deficient aiet 
Rabbit 1 1206 1300 1412 1470 1400 1352 1408 1424 1510 1500 1520 1520 1570 1608 1606 1606 1678 1798 1810 1866 1870 
Rabbit 2 856 1002 1114 988 1192 1260 1300 1376 1446 1448 1460 1546 1604 1660 1600 1610 1658 1712 1720 1782 1794 
Group VI 
Vit. B deficient diet + 
Sulfanilamide 
Rabbit 1 1030 1124 1162 1180 1256 1290 1248 1228 1270 1346 1300 1250 1280 1304 1368 1454 1500 1540 1604 1612 1616 
Rabbit 2 918 900 862 960 1000 1106 1189 1246 1240 1240 1254 1242 1260 1300 1320 1382 1412 1460 1570 1552 1588 
Group VII 
Vit. A & B deficient diet 
Rabbit 1 914 970 1108 1222 1224 1336 1414 1506 1340 1440 1456 1418 1514 1562 1660 1620 1656 1676 1666 1676 1686 
Rabbit 2 1112 1036 1088 1076 1022 1226 1292 1264 1274 1384 - -- -- loW ON a.* WP *OW WOR4W WOWOO WWWO 
Group VIII1 
Vit. A & deficient diet 
+ Sulfa. 
Rabbit 1 1066 1122 1224 1260 1324 1386 1416 1390 1260 1118 -2 OW WO ONO .010 We WO WM WO 
second rabbit in groups II and VIII. 
"Rabbits died. 
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rate was 11.2 gm. per day, a decrease of 114 per cent over 
group I. The sulfanilamide administered rabbit, group VIII, 
died on the 27th day. The growth rate was 17.1 gm. per day up 
to that time. 
Quantity of Urine 
Quantity of urine was recorded in ml. per kg. body weight 
per 24 hours, as shown in Table 3 and Fig. 2. The urinary ex- 
cretion was not uniform. Group I, control rabbits, excreted an 
average of 80.6 ml. of urine/kg. body weight per day, but the 
sulfanilamide administered rabbit, group II, produced 11 per 
cent less urine. Urinary excretion was increased from the 15th 
to the 30th day in group II, and thereafter, a decrease was 
noted. 
In group III, vitamin A deficient rabbits, there was a 
slight increase in excretion of urine, 12 per cent over group I. 
Sulfanilamide treatment in vitamin A deficient rabbits, group IV, 
excreted 14 per cent less urine than group III, but 8.3 per cent 
more than group II. Increased excretion of urine from the 12th 
to the 21st day was noticed, and a decrease thereafter. 
Vitamin E deficient rabbits, group V, excreted less urine 
than groups I and III, by 6.9 per cent and 19 per cent, respect- 
ively. Sulfanilamide administration in vitamin E deficient 
rabbits, group VI, produced less urinary excretion than groups 
II and IV, by 3.3 and 12 per cents, respectively. After 48 days 
of the experiment there was increased urine excretion noted in 
groups V and VI. 
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Table 3. Urine quantity excreted by various experimental groups.1 
0 6 9 12 15 18 21 
Collection day 
24 27 30 33 36 39 42 45 48 51 54 57 60 
Group I 
Basal diet 80 101 118 78 104 95 87 65 72 87 60 71 75 68 70 102 74 66 82 76 62 
Group II 62 81 74 85 66 81 110 112 98 62 88 52 58 50 62 58 55 69 60 58 58 
Basal diet + 
Sulfanilamide 
Group III 71 82 66 98 70 68 86 78 100 96 110 86 120 85 106 95 136 82 101 74 88 
Vit. A deficient diet 
Group IV 
Vit. A deficient diet + 
80 74 68 60 92 103 115 98 90 88 56 48 72 64 130 62 72 52 71 66 53 
Sulfanilamide 
Group V 65 81 76 50 69 72 65 80 56 51 54 41 57 62 84 53 129 113 110 101 111 Vit. deficient diet 
Group VI 92 45 53 74 62 44 60 54 46 68 30 54 46 50 65 68 71 84 92 110 106 
Vit. E deficient diet + 
Sulfanilamide 
Group VII 84 76 59 55 56 62 88 71 81 95 102 110 80 122 108 88 72 86 95 92 109 
Vit. A & E deficient diet 
Group VIII 72 52 48 44 58 52 48 36 40 20 2 WWI OM 001.10 .0100101 O.P# Oti 01.1.110 OIDAIS alt.& OIWOMPO 0.* 00 MO 
Vit. A & IL deficient diet 
+ Sulfa. 
lAverage ml. kg. body weight/day. 
2 Rabbit died. 
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Group VII, vitamin A and E deficient rabbits, excreted 
slightly more urine than group I, by 6.3 per cent. Sulfanila- 
mide administration in vitamin A and deficient rabbits elic- 
ited a marked decrease in excretion of urine. 
Sulfanilamide in Urine 
The per cent of total excretion of sulfanilamide includes 
free and acetylated form of sulfanilamide in urine, as shown in 
Table 4 and Fig. 3. Control group, No. II, excreted an average 
of 75.9 per cent of the total drug administered, of which 42.3 
per cent was in free form and 33.6 per cent was in acetylated 
form. 
Sulfanilamide administration in vitamin A deficient rabbits, 
group IV, produced excretion of 10.4 per cent less total sulfa- 
nilamide than group II. There was an increase of 12.6 per cent 
in the free form and a decrease in the acetylated form of 12.7 
per cent as compared to controls. 
Sulfanilamide administration in deficient rabbits, group 
VI, promoted excretion of 5.4 per cent total sulfanilamide over 
group II. There was a decrease of 15.6 per cent of the free form 
and an increase of 13.6 per cent of the acetylated form of the 
drug, over the controls. 
Sulfanilamide administration in A and E deficient rabbits, 
group VIII, caused excretion of 29.3 per cent less of the total 
drug than the controls, with a decrease in free and acetylated 
forms of drug during the 27 days. 
Table 4. Urinary sulfanilamide excretion by various exvrimental groups. 
4.2 
02 3 6 9 12 15 18 21 
Collection day 
24 27 30 33 36 39 42 45 48 51 54 57 60 
Group II 
Das1 diet + Sulfanilamide 
Free form 
Acetylated form 
Total drug 
Group IV 
Vit. A deficient diet + 
Sulfanilamide 
Free form 
Acetylated form 
Total drug 
Group VI 
Vit. i deficient diet + 
Sulfanilamide 
Free form 
Acetylated form 
Total drug 
Group VIII 
Vit. A 4, E deficient d 
+ Sulfanilamide 
Free form 
Acetylated form 
Total drug 
.000* 
OW MO 
4110,411* 
AO*6110 
10.01101O. 
001,70000 
.PO0* 
M00, 
39 
23 
62 
37 
47 
84 
47 
41 
88 
42 
29 
71 
40 
41 
81 
45 
32 
77 
39 
39 
78 
40 
36 
76 
32 
25 
57 
42 
36 
78 
31 
41 
72 
53 
32 
85 
55 
35 
90 
35 
33 
68 
24 
56 
80 
29 
34 
63 
40 
31 
71 
41 
40 
81 
33 
53 
86 
16 
40 
56 
56 
30 
86 
43 
32 
75 
25 
47 
72 
21 
31 
52 
42 
32 
74 
34 
31 
65 
41 
43 
84 
32 
22 
54 
54 
28 
82 
54 
16 
70 
39 
56 
95 
42 
18 
60 
49 
28 
77 
57 
21 
78 
34 
58 
92 
43 
12 
55 
36 
34 
70 
46 
16 
62 
40 
53 
93 
56 
26 
82 
46 
18 
64 
30 
50 
80 
aw 
1111, VAIN 
50 
29 
79 
41 
15 
56 
38 
58 
96 
.10 or. 
32 
36 
68 
51 
10 
61 
32 
48 
80 
OlOOlmo. 
36 
44 
80 
57 
12 
69 
40 
42 
82 
4111P new 
33 
32 
65 
52 
11 
63 
36 
45 
81 
30 
44 
74 
50 
16 
66 
27 
50 
77 
40 
42 
82 
42 
13 
55 
28 
41 
69 
36 
40 
76 
52 
8 
60 
28 
37 
65 
50 
31 
81 
47 
14 
61 
36 
34 
70 
40 
42 
82 
56 
12 
68 
25 
37 
62 
1Average percentage excretion of the Sulfa administered. 
2No administration of Sulfa drug. 
3Rabbit died. 
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Urinary Urea Nitrogen 
The amounts of urinary urea nitrogen are illustrated in 
Table 5 and Fig. 4. The excretion of urea nitrogen was not 
uniform, but there was increase in groups II, IV, and VI in the 
terminal days of the experiment. 
Group I rabbits excreted an average of 306.5 mg./kg./day, 
but the rabbits administered sulfanilamide, group II, produced 
an average of 30.6 per cent more urea nitrogen than group I. 
Group III, vitamin A deficient rabbits, produced low levels 
of urea nitrogen amounting to 24.6 per cent less than group I. 
Group IV, sulfanilamide administered rabbits, excreted 30 per 
cent more urea nitrogen than group III, but 22.4 per cent less 
than group II. 
Group V, vitamin E deficient rabbits, produced only 1.6 
per cent more urea nitrogen than group I, and group VI, admin- 
istered sulfanilamide, excreted 32.5, 35.3, and 30.3 per cents 
more urea nitrogen than groups I, IV, and V, respectively. 
In group VII, vitamin A and E deficient rabbits, less urea 
nitrogen was excreted than groups I and III by 34.7 and 15.5 per 
cents less, respectively; and the sulfanilamide administered 
rabbits, group VIII, produced 40 per cent more urea nitrogen 
than group VII and 29.8 per cent less than group U. 
Creatine and Creatinine in Urine 
The amounts of creatine and creatinine excreted in urine 
are depicted in Table 6 and Fig. 5, and are expressed in mg./ 
kg./day. 
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Table 5. Urinary urea nitrogen excretion by various experimental groups. 
1 
42 45 48 51 54 57 60 0 6 9 12 15 18 21 24 
Collection day 
27 30 33 36 39 
Group I 
basal diet 
462 314 218 360 248 310 256 308 342 208 384 236 196 262 297 314 356 362 280 368 356 
Group II 346 309 242 436 402 341 388 494 522 452 488 442 316 374 377 508 236 442 468 311 586 
Basal diet + Sulfanilamide 
Group III 352 322 190 220 251 188 210 215 198 202 172 132 145 186 200 212 256 185 112 206 308 
Vit. A deficient diet 
Group IV 296 430 239 402 388 342 232 342 332 185 161 182 200 112 162 254 416 376 486 310 386 
Vit. A deficient diet + 
Sulfanilamide 
Group V 327 308 276 310 368 374 260 388 281 206 196 231 216 374 206 416 321 370 378 420 316 
Vit. E deficient diet 
Group VI 386 302 376 410 410 204 378 360 346 368 390 406 305 46.6 488 460 546 416 562 500 562 
Vit. E deficient diet + 
Sulfanilamide 
Group VII 312 366 410 301 211 251 150 138 155 141 120 174 202 183 168 170 87 138 218 143 182 
Vit. A & E deficient diet 
Group VIII 394 380 365 406 374 218 138 181 182 171 -_-2 00* 4. *00 IOW IN* aill a. *Se 0NO 00* osfsemm* 0. taw** swed.mw * 
Vit. A & E deficient diet 
Sulfa. 
lAverage mg./kg. body weight/day. 
2Rabbit died. 
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Table 6. Urinary creatinine and creatine excretion by various experimental groups. 
0 6 9 12 15 18 21 24 
IN* 
Collection uay 
27 30 33 36 39 42 45 48 51 54 57 60 
Group I 
Basal diet 
Creatinine 41 36 38 35 42 55 30 48 48 36 31 42 35 58 37 40 42 36 48 52 42 
Creatine 0 2 0 4 2 4 0 2 3 0 0 4 6 3 0 0 2 4 2 4 2 
Group II 
Basal diet 4- Sulfanilamide 
Creatinine 46 45 42 74 68 82 92 88 112 55 75 74 111 87 80 108 78 82 88 94 75 
Creatine 2 2 4 2 2 2 8 0 12 2 4 2 7 2 0 10 2 8 6 16 2 
Group III 
Vit. A deficient diet 
Creatinine 50 45 36 46 46 33 36 46 44 40 48 46 49 41 40 48 49 42 53 55 58 
Creatine 2 2 2 4 2 2 4 2 4 2 0 2 6 2 2 4 4 2 4 2 4 
Group IV 
Vit. A deficient diet + 
Sulfanilamide 
Creatinine 56 54 48 52 78 86 87 92 95 112 107 85 111 49 108 114 118 100 96 78 86 
Creatine 2 0 2 4 2 4 2 12 4 8 4 2 8 6 10 2 8 2 2 2 
Group V 
Vit. E deficient diet 
Creatinine 48 49 48 52 57 40 55 62 102 105 114 108 68 78 86 85 92 86 116 126 112 
Creatine 2 2 2 0 8 6 2 4 16 8 22 4 10 7 26 0 26 10 32 28 29 
Group VI 
Vit. deficient diet + 
Sulfanilamide 
Creatinine 51 46 52 56 69 78 77 80 85 106 128 118 86 94 105 110 101 136 126 116 130 
Creatine 2 0 6 2 4 0 2 8 4 27 12 18 10 6 2 4 16 46 41 32 18 
Group VII 
Vit. A & L deficient diet 
Creatinine 55 67 56 54 72 76 78 80 86 92 105 82 88 110 106 87 84 91 112 115 122 
Creatine 0 4 2 6 2 6 0 12 12 16 6 14 16 22 8 16 20 12 28 30 34 
Group VIII 
Vit. A & It. deficient diet 
+ Sulfa. 2 
Creatinine 50 54 46 80 96 102 136 155 150 160 -- *41Of .001.10 MOO! mow -MO O.! AMMO 000* MOW ON 
Creatine 2 4 0 11 21 8 12 58 22 28 -- 400 .10 01111 .111 MOW Oa MO NIP 11.110 
4.7 
1 
Average mg./kg. body weight/day. 
2 Rabbit died. 
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Sulfanilamide administered rabbits, group II, on the aver- 
age, excreted more creatinine (95.8 per cent) than group I. 
There was not much change in creatinine and creatine levels 
in vitamin A deficient rabbits, group III, but in the sulfanil- 
amide administered rabbits, group IV, there was an increase in 
creatinine levels: 105.9 per cent over group I and 11 per cent 
over group II. 
Vitamin L deficient rabbits, group V, excreted wore crea- 
tinine and creatine (189 and 44 per cents, respectively) than 
group I. In sulfanilamide administered rabbits, group VI, 142 
per cent more creatinine was produced than in group I, and 28 
per cent more than in group V, but it produced no effect on 
creatine levels. 
croup VIII vitamin A and r. deficient rabbits, excreted 13 
and 10 per cents more creatinine and creatine, respectively, 
than group V; and the sulfanilamide administered rabbits, group 
VIII, produced more creatinine and creatine than groups VI or 
VII in the 27 day period. The greater excretion was elicited 
prior to death. 
The creatine and creatinine levels were augmented in later 
stages of deficiency of vitamin E and in sulfanilamide adminis- 
trated groups. 
Sulfanilamide in Blood 
The number of mg. present in 100 ml. of blood is depicted 
in Table 7 and Fig. 6. Sulfanilamide administration in groups 
50 
Table 7. blood sulfanilamide of various experimental rabbits. 1 
Group 
ollection day 
0 60 
:Rabbit : 
:No. 1 : 
Rabbit :Rabbit : 
No. 2 :No. 1 : 
Rabbit 
No. 2 
Group II 
basal diet + Sulfanilamide 
Free form 
Acetylated form 
Total drug 
Group IV 
Vit. A deficient diet 
Free form 
Acetylated form 
Total drug 
Group VI 
Vit. i deficient diet + 
Sulfanilamide 
Free form 
Acetylated form 
Total drug 
Group VIII 
Vit. A & L deficient diet 
+ Sulfa. 
Free form 
Acetylated form 
Total drug 
2 
1.10 
001. 1101 
2 
OW! 
MY 
N. WM/ 
2 
SNOOP 
41111 lain 
Sii" +NI 
2 
.111. 44.1 
gOer 
2 
OP 100 
M. NM 
MOW AM* 
2 
MOO* 
2 
INO MEV 
2 
M. no* 
32 
8 
40 
54 
5 
59 
21 
33 
44 
61 
6 
67 
3 
ROO 00 
ARP 4011.1 
52 
4 
6 
56 
30 
22 
52 
3 
011,M10 
ling./100 ml. of blood of each rabbit 
2No drug had been given on zero day (blood collected before 
treatment started). 
3Rabbit died in pre-experimental period. 
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52 
IV, vitamin A deficient rabbits, VI, vitamin E deficient rabbits, 
and VIII, vitamin A and deficient rabbits, demonstrated eleva- 
ted levels of the total drug in the blood by 43.7, 20, and 67.5 
per cents, respectively, over the control. Increased free form 
of the drug was noted in groups IV and VIII by 12.1 and 11 per 
cents, respectively, over the control group (II). Decreased 
acetylated form of the drug was seen in groups IV and VIII by 
12.2 and 11 per cents, respectively, over the control group (II). 
In A deficient animals, group VI, the acetylated form was in- 
creased and the free form decreased by 27 per cent. 
Blood Urea Nitrogen 
Blood urea nitrogen in blood is depicted in Table 8 and 
Fig. 7. Blood urea nitrogen was lower in groups III and VII by 
20.4 and 31.8 per cents, respectively, than control group I. 
Groups II, IV, V, VI, and VIII had higher blood urea nitrogen by 
55, 68.1, 52.3, 77.2, and 173 per cents, respectively, than the 
control group II. 
Blood Creatinine and Creatine 
Determinations of blood creatinine and creatine were not 
completed due to coagulation of the blood sample. 
Packed Cell Volume 
The results of P.C.V. values are illustrated in Table 9 
and Fig. 8. The P.C.V. values were affected progressively with 
the treatment of sulfanilamide. 
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Table 8. Blood urea nitrogen of various experimental rabbits) 
Group 
Collection day 
0 60 
:Rabbit : 
:No. 1 : 
Rabbit :Rabbit : 
No. 2 :No. 1 : 
Rabbit 
No. 2 
Group I 48 38 42 46 
Basal diet 
Group II 36 
2 
-WO 68 
2 
AM 
Basal diet 4 Sulfanilamide 
Group III 52 42 32 38 
Vit. A deficient diet 
Group IV 44 36 82 66 
Vit. A deficient diet + 
Sulfanilamide 
Group V 42 50 64 70 
Vit. E. deficient diet 
Group VI 55 44 84 72 
Vit. i deficient diet + 
bulfanilamide 
Group VII 35 40 66 303 
Vit. A & deficient diet 
2 
Group VIII 50 42 112 INNY 
Vit. A & deficient diet 
+ Sulfa. 
mg./100 ml, of blood of each rabbit. 
2Rabbit died in pre-experimental period. 
3Rabbit died on 27th day. 
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Table 9. Packed cell volume of various experimental rabbits.1 
Group 
Collection day 
0 . 30 : 60 
:Rabbit No.:Rabbit No. :Rabbit No. 
: 1 2 : 1 2 : 1 2 
Group 46 45 45 44 45 45 
Basal diet 
Group II 47 -- 2 39 2 36 __2 
Basal diet 4. Sulfanilamide 
Group III 46 45 41 40 40 38 
Vit. A deficient diet 
Group IV 46 44 39 31 34 28 
Vit. a deficient diet t 
Sulfanilamide 
Group V 48 45 40 36 39 38 
Vit. deficient diet 
Group VI 48 4.8 37 34 28 31 
Vit. E deficient diet + 
Sulfanilamide 
Group VII 44 44 35 40 36 --3 
Vit. A & E deficient diet 
3 2 Group VIII 46 --2 263 4110 
Vit. A & E. deficient diet 
4. Sulfa. 
17K1. of red blood cells/100 ml. blood. 
2Rabbits died in pre-experimental period. 
3Rabbits died on 27th day. 
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Table 10. Averaged values of the vrious constituents of blood and urine for the 60 day treatment. 
----- 
-7=7= --- -0.-- 
Group I : Croup II : Group III : Group Group 
. 
: :`vit. , aa- . . 
. 
. 
: Vit. A :ficient diet : 
. 
: Basal aiet + : deficient :4. Sulfanila- :Vit. i. de- :t Sulfenila- :deficient : diet + 
mide :ficient uiet : mide : diet : Sulfa. 
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Group VI : Group VII :Group VIII 
:Vit. fi; de- : :Vit. A & 1. 
:ficient diet :Vit. A & E :deficient 
:Basal diet: Sulfanilamide: diet 
Gain of body weight in grams/ 27 20.8 
clay 
Quantity of urine excreted 1 
Per cent of total sulfanilamide 
excreted in urine 
Per cent of free form of drug 
in urine 
Per cent of acetyleted form in 
urine 
Amount of urea nitrogen ex- 
creted 
Amount of creatinine excreted2 
Amount of creetine excreted2 
Packed cell volume4 
Total sulfanilamide in blood3 
fq-ee form in blood3 
Acetylated form An blood3 
Urea nitrogen in blood3 
80.6 
1111111 wimp 
306.5 
71.1 
75.9 
42.3 
33.6 
400.0 
17.4 
90.4 
*NIA IMP 
ad. W. . 
OW OM 
231.0 
14.8 
77.0 
68.0 
46.4 
21.6 
300.4 
40.5 79.3 45.3 88.2 
2.1 4.4 2.6 4.3 
45 36 39 31 
....... 40 --- 57.5 
32 
--- 53 
4.5 
44 68 35 74 
AIM Iii 
13.3 
75.0 
OM, .0 
311.5 
76.6 
11.4 
38.5 
01111, WA" 
67 
10.1 
68.7 
80.0 
33.6 
46.4 
406.1 
11.2 
85.0 
200.1 
17.1 
49.0 
63.6 
35.4 
28.2 
280.9 
98.0 87.0 102.0 
11.3 12.6 16.6 
29.5 36 26 
48 -- 67 
25.5 
22.5 
78 
emal OW WO 
30 
61 
6 
112 
;Al./kg. body weight/day. 
'g./kg. body weight/dey. 
31,4g0/100 ml. blood. 
4RBG/l00 ml. blood. 
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Table 11. The various constituents of the blood and urine of the experimental groups, expressed in percentage increase (+) or decrease 
(-) over the two basal groups. 
Group I : Group II : Group III : Group I), : Group V : Group VI : Group VII :Group VIII 
. 
. 
. . :Vit. A oe- . :Vit. e de- : :Vit. il & e 
. 
: Vit. A :ficient diet : :ficient uiet :Vit. A & :deficient 
. 
: Basel diet + : deficient :* Sulfeni1,- :Vit, le de- :+ 3ulfanila- :deficient : diet t 
:Baal diet: ..'')ulfInilamide: diet mide :ficient uiet : miae diet : 
Body weight 
Volume of urine 
1621 
80.6 
Total sulfanilamide in urine 
--- 75.9 
Free fom in urine ___ 42.3 
Acetylated form in urine --- 33.6 
Totel sulfa in blood --- 40 
Free forel in blood ___ 32 
Acetylated form in blood ___ 8 
Urinary urea nitrogen 306.5 +30.6 
Blood urea nitrogen 
Creatinine in urine 
400.0 
44 +55 
68 
40.5 +54.5 
-69 
+12 
IM ONO MO 
.10 
-24.6 
IN. ow 
-20.4 
+11.8 
*,* 
-73 -103 -116 -114 
-4.4 -6.9 -14.7 +6.3 -39.2 
+8.3 ..-.. -3.3 ...... -3.1 
-29.3 
+12.6 --- -15.6 --- -44.2 
-12.7 --- +13.6 --- -0.1 
+43.7 --- +20 __- +67.5 
-,ee / ___ +11 
-12.2 --- +27 -__ -11 
-2.0 +1.6 +32.5 -34.7 -8.2 
-22.4 ...... +1.5 ___ -29.8 
+68.1 +52.3 +77.2 -31.8 +173 
+105.9 +189.1 +141.9 +114.8 +203.7 
.10 eellt 
Note: A or - sign appearing prior to any value indicates the value was compared with the respective basal groups. 
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A stopathological Examination 
histopathological investigations of ureters were elimi- 
nated because the sectioning was not satisfactory. 
Group I, basal diet control group of rabbits, revealed no 
changes in kidney, liver, and bladder sections; but rabbit 1 
exhibited a slight inflammatory change from the liver section. 
Sulfanilamide administered rabbits, group II, showed no changes 
but 6:1 edema in. the kidney tubules. 
Group III, vitamin A deficient rabbits sections, exhibited 
focal areas of necrosis and hydropic degeneration of the liver 
cord cells. Sections from kidney revealed degenerative changes 
in the tubules. Group IV, sulfanilamide administered rabbits, 
showed a cloudy swelling, areas of fibrosis, and a slight con- 
gestion in the liver sections. The kidney tubules demonstrated 
casts in collecting tubules in the lumen, degenerative changes, 
pycknotic nuclei, and necrosis associated with toxic tubular 
nephritis. 
Group V, vitamin F., deficient rabbits, revealed a cloudy 
swelling of liver and areas of mild fibrosis of the bile duct in 
liver sections. Sections from kidney demonstrated marked fibro- 
sis in cortex area with infiltration of mononuclear cells in the 
tubules, and some pink color proteinosis casts in the lumen 
associated with chronic interstitial nephritis. Sections from 
urinary bladder revealed desquamation of epithelial cells associ- 
ated with hydropic degeneration. Group VI, sulfanilamide admin- 
istered rabbits, showed in liver sections, fibrosis of the bile 
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duct with some focal areas of neutrophils. Sections from kidney 
revealed casts and congestive areas in collecting tubules associ- 
ated with interstitial nephritis. Rabbit No. 2 of group VI 
showed scattered areas of irregular deeply blue stained calci- 
fication in the kidney sections. 
Group VII, vitamin A and E deficient rabbit which was sac- 
rif iced on the 27th day, revealed cloudy swelling of the liver. 
The kidney section exhibited edema and colloid material in the 
tubules tdth intact glomeruli in Bowmen's capsules. The other 
rabbit (No. 2), which was alive for 60 days, demonstrated cloudy 
swelling of the liver and mononuclear cell infiltration in liver 
sections. The kidney section showed casts in the convoluted 
tubules, reticuloendothelial cell hyperplasia, and pycknotic 
nuclei leading to chronic interstitial nephritis. Sulfanilamide 
feu rabbit, group VIII, which died on the 27th day, showed hyper- 
plasia of bile duct and proliferation of Kupffer cells in liver 
sections. Kidney sections revealed casts in tubules, glomeruli 
were intact in Bowmen's capsules, and degenerative changes. Sec- 
tions from bladder revealed diffuse hemorrhage and desquamation 
of epithelial cells. 
DISCUSSION 
Acetylation as a mode of detoxication of sulfanilamide 
drugs has been known for a long time. Marshall (76) and Krebs, 
et al. (65) have shown in their experiments that dogs do not 
acetylate sulfanilamides. Later work of Marshall (76) has shown 
that deacetylation takes place before urinary excretion. This 
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demonstrated that there is a speciee difference in metabolism of 
sulfenilemides. The liver as the site of acetylation in rabbits 
end rats was demonstrated by Harris and Michel (40), while spleen 
appeared to take part in cats (123). 
Acetylation is accelerated by the presence of acetic acid 
or acetic acid precursors in the body (51, 79). In thiamine 
deficiency, pyrievic acid cannot be converted to acetyl co A and, 
hence, acetylation is depressed as evidenced by the eork of 
Martin and Rennebaum (79) and mentioned by Sollmann (112), who 
also cited that the diphosphothiamin redox system is involved. 
How acetylation is decreased in riboflavin deficiency has not 
been sufficiently explained. Folic acid has been proved (56) 
to be necessary in acetylation mechanism. Acetylation of sul- 
fanilamides and their derivatives in pigeon liver extracts were 
markedly inhibited noncompetetively by 4-aminoanalogues of folic 
acid and aminopterin, which are folic acid antagonists. 
Krebs, et al. (65) were of the opinion that the extent of 
acetylation also depended upon the competition between acetyla- 
tion and deacetylation enzymes. Cholesterol is synthesized in 
the liver by coenzyme of acetic acid fragments. There is a con- 
troversial opinion regarding the role of vitamin A in cholesterol 
synthesis. However, Meyer (84) has shown that in a deficiency of 
vitamin A, there was a depressed formation of chondroitin sul- 
phate and other mucopolysaccharides which contain acetylated 
derivatives of glucosamine or chondrosinine. Thus, it is evident 
that vitamin A has a function in acetylation reactions. There 
62 
is no evidence cited in literature that vitamin E takes part in 
acetylation. 
The results of the present experiments showed that acetyla- 
tion of sulfanilamide decreased in vitamin A deficient animals. 
In deficiency where vitamin A was provided in the diet, acety- 
lation was augmented. This increase in acetylation may be due 
to the presence of vitamin A. No conclusions are drawn in 
vitamin A and E deficient animals, as they died prematurely. 
In the light of previous findings (84, 89) and the results of 
the present experiments, it may be concluded that vitamin A 
takes part it acetylation, whether in detoxication or in the 
synthesis of mucopolysaccharides anu in cholesterol. 
From the results obtained, the excretion of total sulfa- 
nilamide was decreased showing a greater retention of sulfanil- 
amide in blood of vitamin A deficient animals. Comparative to 
control animals with sulfanilamide there was an increase of 43.7 
per cent in retention of total sulfanilamide in blood, and 60.3 
per cent of free form of drug was retained in avitaminosis A. 
There was a depression of about 43.7 per cent of the acetylated 
form in blood. The results indicate that there was a greater 
retention of total sulfa and a rise in retention of free form of 
sulfanilamide. The fall in the acetylated sulfanilamide in blood 
and urine in vitamin A deficient animals suggests that the acety- 
lation mechanism of sulfanilamide itself deficient, and the 
decreased elimination was not due to retention of the acetylated 
form in blood. It was assumed that the elimination of sulfa- 
nilamide sources other than urine was equal in all groups. The 
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urine pH of all groups remained alkaline in which the free and 
acetyl derivatives are soluble. 
It was proved by Marshall (76) that sulfanilamide after 
acetylation in the body had no therapeutic affect. Inasmuch as 
acetylation of sulfanilamide was decreased in vitamin A defi- 
ciency, the level of free sulfanilamide in the body will be 
elevated. It can be deduceu from this that in avitaminosis A 
condition, the effective dosage of sulfanilamide can be reduced. 
v'oelfel, et al. (I 8) reported that vitamin A deficient 
calves excreted excess urine. In the present experiment the 
vitamin A deficient and vitamin A and deficient rabbits ex- 
creted larger quantities of urine wnen comp,--red to controls. 
Administration of sulfanilamide to controls, vitamin A deficient, 
vitamin E. deficient, and vitamin A and E deficient animals de- 
pn'ssed the volume of urine compared to the normal controls. 
Jones (58) mentioned that the administration of sulfanil- 
amides produced an elevated urinary volume in the beginning and 
a depressed volume thereafter, producing anuria. In the present 
experiment there was a tendency that urine volume would increase 
with slight fluctuations up to the 30th aay then decrease. In 
vitamin E deficient animal the volume of urine was increased 
after 48 days. 
In the present experiments the urine pH remained alkaline, 
at which free and acetylated form of sulfanilamide could not be 
precitipated. Thus, the possibility of crystallization of sulfa- 
nilamide in renal tubules and consequent blocking may not be a 
factor for decreased urine elimination. In sulfanilamide therapy, 
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it was reported (73, 112), acidosis results as a result of in- 
hibition of carbonic anhydrase. Acidosis decreases the blood 
pressure, and as a result, the glomerular filtration is decreased, 
and consequently, there was less formation of urine. 
Woelfel, at al. (128) reported that there was a fall in 
excretion of urea nitrogen in calves deficient in vitamin A, due 
to renal dysfunction. Increased urinary urea nitrogen in vitamin 
deficient mice was reported by McGaughey (81). The results of 
the present experiment coincide with the above workers. 
In the present experiments a similar depression of urinary 
urea nitrogen was found in vitamin A deficient and vitamin A and 
E deficient animals; however, there was an increase in sulfanil- 
amide fed groups. The decrease of urea nitrogen in the vitamin A 
deficient animal was about 24.6 per cent more than group I, 
whereas in the sulfanilamide fed animals there was also a fall, 
22.4 per cent less than group II. The blood urea nitrogen was 
also depressed in group III and group VII by 20.4 and 31.8 per 
cents, respectively, as compared to group I; in other groups it 
WAS elevated. 
In vitamin A deficiency, the depressed urea formation may 
be ascribed to decreased absorption of amino acids and consequent 
lowered deaminetion in the liver, or it may be due to patholog- 
ical changes taking place in the liver or kidney. 
The concentration of crestinine and creatine did not vary 
much between controls and avitaminosis A rabbits in the present 
experiments. There ves a great increase in creatine and creeti- 
nine elimination in vitamin E deficient animals. These findings 
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agree with the results obtained by previous workers (1) and 
(10). In avitaminosis E animals the creatine excretion was 
higher. This suggested that conversion of creatine to creatinine 
in vitamin E deficient animals was low. However, with the ad- 
ministration of sulfanilamide to control, vitamin A deficient, 
vitamin E deficient, and vitamin A and E deficient animals, both 
creatine and creatinine elimination was promoted. 
Growth rate in vitamin A and/or deficient animals was 
decreased. In sulfanilamide fed groups the growth rate was lower 
than in their controls. Group VI showed the lowest rate of 
growth. The depressed growth rate in sulfanilamide administered 
groups may be attributed to an increased excretion of creatinine 
and creatine. However, there was no correlationship between 
avitaminosis A and in creatine and creatinine excretion. The 
increase in creatinine elimination in vitamin A deficient ani- 
mals compared to controls was about 12 per cent, whereas the 
sulfanilamide fed group was 11 per cent over group II. 
Packed cell volume values were altered in all groups of 
animals, but they were greatly affected in the sulfanilamide fed 
groups, which indicated that it might be due to anemia as re- 
ported by other workers (49, 61). 
The avitaminosis A animals, as compared to sulfanilamide 
administration in vitamin A deficient animals, elicited exag- 
gerated and progressive degenerative changes in the liver and 
kidney sections. Liver sections demonstrated cloudy swelling 
and fibrosis, and the kidney showed tubular casts, degenerative 
changes and pyknotic nuclei which were suggestive of toxic 
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tubular nephritis. 
The kidney changes in avitaminosis E deficient rabbits were 
suggestive of chronic interstitial nephritis. Administration of 
sulfanilamide in vitamin E deficient group, in addition to 
chronic interstitial nephritis, also revealed congestive areas 
in renal collecting tubules. The liver revealed cloudy swelling 
and mild fibrosis of bile duct and some focal areas of neutro- 
phil infiltration. 
The lesions in vitamin A and E deficient group were more 
severe as evidenced by edema, colloid material in kidney tubules 
with mononuclear cell infiltration and hyperplasia of reticulo- 
endothelial cells associated with chronic interstitial nephritis. 
Sulfanilamide administration in A and E deficient animal revealed 
proliferation of liver Kupffer cells and hyperplasia of bile duct 
accompanied by other degenerative changes in kidney and liver 
sections. The bladder section showed a diffuse hemorrhage and 
desquamation of epithelial cells. 
The progressive deterioration of the liver and kidney of 
vitamin A and /or E deficiency with sulfanilamide administration 
was suggestive of toxic effects on these tissues. The changes 
in blood and urine discussed above might be the result of degen- 
erative changes taking place in liver and kidney. No deposition 
of crystals of sulfanilamide could be detected in the sections. 
SUMMARY AND CONCLUSIONS 
The experiment was conducted to determine the effect of 
sulfanilamide toxicity and excretion employing vitamin A de- 
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ficient, vitamin 6 deficient, and vitamin A and t deficient 
animals. 
Sixteen rabbits were divided into 8 groups, each containing 
2 animals. A synthetic diet deficient in vitamin A and/or E was 
fed to various groups of rabbits, while one group serving as 
control was fed added vitamin A and E. Sulfanilamide was admin- 
istered every day to the normal control and groups fed deficient 
aiet of vitamin A and/or E (4 groups including control). 
The growth rate, volume of urine, free and acetylated form 
of sulfanilamide in blood and urine, urea nitrogen in blood and 
urine, creatine and creatinine in urine, and packed cell volume 
values were determined. The animals were sacrificed after 60 
days treatment and histopathological sections of liver, kidney, 
and urinary bladder were studied. 
The administration of sulfanilamide to animals fed vitamin 
A deficient diet resulted in decreased elimination of acetylated 
form of sulfanilamide in urine while maintaining higher levels 
of free drug in circulation. 
The volume of urine was depressed progressively in all the 
animals treated with sulfanilamide inclusive of group given 
normal diet with sulfanilamide. 
The urea nitrogen excretion in avitaminosis A animals was 
24.6 per cent less than the controls. However, sulfanilamiue 
administration to vitamin A deficient animals demonstrated an 
increased urea nitrogen elimination with higher blood urea nitro- 
gen levels. 
The creatine and creatinine excretion was greater in vitamin 
deficient animals. Administration of sulfanilamide in all 4 
groups resulted in an increase in total quantity of creatine and 
cr atinine urinary excretion. 
The packed cell volume values were lower in sulfanilamide 
administered groups when compared to their controls. 
In the comparison of depressed growth rate of animals fed 
vitamin A and/or E deficient diets, the sulfanilamide adminis- 
tered groups lost considerable weight. 
The histopathological sections revealed that vitamin A and/ 
or L deficiency were of a cellular degenerative type, cloudy 
siNelling of liver, mild fibrosis of bile duct, and degenerative 
changes in the renal tubules. Sulfanilamide administrations 
aggravated the histopathological changes which were attributed 
to the toxicity of the drug. 
From the results obtained, it may be concluded that the 
therapeutic dosage of sulfanilamide in avitaminosis A could be 
profitably reduced maintaining the therapeutic efficiency. 
Prolonged treatment with sulfanilamide has been shown to 
have a deleterious effect on growth rate, even in normal animals. 
The experiment seems to indirectly prove that vitamin A 
takes part in detoxication mechanism by acetylating some of the 
foreign organic compounds like sulfanilamide. 
The conclusions from this study have been drawn with con- 
siderable reservation, as the number of experimental animals em- 
ployed in these experiments may be considered insufficient for 
sound and safe deduction. 
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Sulfanilamide drugs are employed extensively in large animal 
practice. Nutritional deficiencies, such as avitaminosis A and/ 
or E and related disorders, are common among livestock. The ef- 
fects of sulfanilamide administration in these conditions have 
not been studied. These experiments were designed to investigate 
certain effects of administering sulfanilamide to rabbits re- 
ceiving diets deficient in vitamin A or vitamin E, and vitamins 
A and E. 
Sixteen New Zealand white rabbits were divided into eight 
grou?s, each containing two animals. A synthetic diet deficient 
in vitamin A and/or E was fed to various groups, while one group 
serving as the controls received added vitamins A and E. Sulfa- 
nilamide was administered daily (250 mg./kg./day) to the normal 
control and groups fed deficient diet of vitamin A and/or E. 
The animals were sacrificed after sixty days treatment, and 
histopathological sections of liver, kidney, and urinary bladder 
were studied. Urine samples were collected and volume measured 
every third day; and blood samples were collected on 0 and 60th 
days for analysis of free and acetylated form of sulfanilamide, 
urea nitrogen, creatine, and creatinine. Packed cell volume 
determinations were made on 0, 30th, and 60th days, and body 
weights recorded every third day. 
The administration of sulfanilamide to animals fed vitamin A 
deficient diet resulted in a decreased elimination of acetylated 
form of sulfanilamide in urine while maintaining higher levels 
of free drug in circulation. 
The volume of urine was depressed progressively in all the 
2 
animals treated with sulfanilamide, inclusive of group given 
basal diet with sulfanilamide. 
The urea nitrogen excretion in avitaminosis A rabbits was 
less than the controls. However, sulfanilamide administration 
to vitamin A deficient animals demonstrated an increased urea 
nitrogen elimination with higher blood urea nitrogen levels. 
The creatine, creatinine excretion was greater in vitamin E 
deficient animals. Administration of sulfanilamide in all four 
groups resulted in an increase in total quantity of creatine and 
creatinine urinary excretion. 
The packed cell volume values were lower in sulfanilamide 
administered groups when compared to their controls. 
In the comparison of depressed growth rate of animals fed 
vitamin A and/or E deficient diets, the sulfanilamide admin- 
istered groups lost considerable weight. 
The histopathological sections revealed that vitamin A 
and/or E deficiency was of a cellular degenerative type cloudy 
swelling of liver, mild fibrosis of bile duct, and degenerative 
changes in the renal tubules. Sulfanilamide administration ag- 
gravated the histopathological changes. 
From the results obtained it may be concluded that the 
therapeutic dosage of sulfanilamide in avitaminosis A could be 
profitably reduced, maintaining the therapeutic efficiency. 
Prolonged treatment with sulfanilamide has been shown to 
have a deleterious effect on growth rate, even in normal animals. 
The experiments seem to indirectly prove that vitamin A 
takes part in detoxication mechanisms by acetylating some of the 
3 
foreign organic compounds like sulfanilamide. 
The conclusions from this study have been drawn with con- 
siderable reservation, as the number of experimental animals 
employed in these experiments may be considered insufficient 
for sound and safe deductions. 
